Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3699395018 | Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3759878013 | Product containing precisely fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation | est un(e) (attribut) | Fluticasone and salmeterol only product in pulmonary dose form | true | Inferred relationship | Some | ||
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation | Has basis of strength substance (attribute) | Fluticasone propionate (substance) | true | Inferred relationship | Some | 2 | |
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation | Has precise active ingredient | Salmeterol xinafoate | true | Inferred relationship | Some | 1 | |
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation | Has presentation strength numerator value (attribute) | 500 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation | Has presentation strength denominator unit (attribute) | Actuation (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation | est un(e) (attribut) | Product manufactured as pulmonary dose form (product) | false | Inferred relationship | Some | ||
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation | Has unit of presentation | Actuation (unit of presentation) | true | Inferred relationship | Some | ||
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation | est un(e) (attribut) | médicament contenant fluticasone et salmétérol | false | Inferred relationship | Some | ||
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation | Has presentation strength numerator unit | microgram (qualifier value) | true | Inferred relationship | Some | 2 | |
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation | Has basis of strength substance (attribute) | Salmeterol (substance) | true | Inferred relationship | Some | 1 | |
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation | a une forme pharmaceutique (attribut) | poudre pour inhalation | true | Inferred relationship | Some | ||
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation | Has precise active ingredient | Fluticasone propionate (substance) | true | Inferred relationship | Some | 2 | |
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation | Has presentation strength numerator value (attribute) | 50 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation | Has presentation strength denominator unit (attribute) | Actuation (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation | Has presentation strength numerator unit | microgram (qualifier value) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR